C. Grant

发表

Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

D. Vergani, G. Mieli-Vergani, C. Grant, 2015, Autoimmunity reviews.

Liver immunology: How to reconcile tolerance with autoimmunity.

C. Grant, R. Liberal, 2017, Clinics and research in hepatology and gastroenterology.

Autoimmune hepatitis: a comprehensive review.

D. Vergani, G. Mieli-Vergani, C. Grant, 2013, Journal of autoimmunity.

T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.

D. Vergani, G. Mieli-Vergani, P. Gordon, 2013, Journal of autoimmunity.

"Porto-pulmonary hypertension: a comprehensive review".

G. Macedo, C. Grant, R. Liberal, 2015, Clinics and research in hepatology and gastroenterology.

The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin‐9/tim‐3 pathway

D. Vergani, G. Mieli-Vergani, C. Grant, 2012, Hepatology.

Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2.

D. Vergani, G. Mieli-Vergani, M. Heneghan, 2014, Journal of autoimmunity.

Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.

S. Constant, K. Bottomly, C. Grant, 1997, Journal of immunology.

Immunosuppressive drugs affect interferon (IFN)‐γ and programmed cell death 1 (PD‐1) kinetics in patients with newly diagnosed autoimmune hepatitis

D. Vergani, G. Mieli-Vergani, M. Heneghan, 2017, Clinical and experimental immunology.

Regulatory T‐cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis

D. Vergani, G. Mieli-Vergani, M. Heneghan, 2017, Hepatology.

Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis.

D. Bogdanos, N. Bizzaro, C. Grant, 2013, Clinics and research in hepatology and gastroenterology.

Autoimmune hepatitis after liver transplantation.

D. Vergani, G. Mieli-Vergani, C. Grant, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and impaired suppression

D. Vergani, G. Mieli-Vergani, M. Heneghan, 2015, Hepatology.

New Insights on the Role of TRP Channels in Calcium Signalling and Immunomodulation: Review of Pathways and Implications for Clinical Practice

B. Davidson, A. Quaglia, B. Fuller, 2021, Clinical Reviews in Allergy & Immunology.

Phenotypic and functional characterization of a CD4+ CD25high FOXP3high regulatory T‐cell population in the dog

C. Grant, Y. Singh, D. Pinheiro, 2011, Immunology.

Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease

D. Vergani, G. Mieli-Vergani, C. Grant, 2015, IUBMB life.

DYSFUNCTIONAL CD39 REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS Short title: CD39 REGULATORY T CELLS IN AUTOIMMUNE HEPATITIS

D. Vergani, G. Mieli-Vergani, S. Robson, 2016 .

Dysfunctional CD39POS regulatory T cells and aberrant control of T‐helper type 17 cells in autoimmune hepatitis

D. Vergani, G. Mieli-Vergani, S. Robson, 2014, Hepatology.

CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.

D. Vergani, G. Mieli-Vergani, M. Heneghan, 2016, Journal of autoimmunity.

D. Vergani, G. Mieli-Vergani, S. Robson, 2015 .

Reply: To PMID 23787765.

D. Vergani, G. Mieli-Vergani, S. Robson, 2015, Hepatology.

Cirrhosis and autoimmune liver disease: Current understanding

C. Grant, R. Liberal, 2016, World journal of hepatology.

Tissue CD14^+CD8^+ T cells reprogrammed by myeloid cells and modulated by LPS

M. Haniffa, Leo Swadling, G. Reynolds, 2023, Nature.

Diagnostic criteria of autoimmune hepatitis.

Rodrigo Liberal, Giorgina Mieli-Vergani, D. Vergani, 2014, Autoimmunity reviews.

DYSFUNCTIONAL CD39 POS REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS

D. Vergani, G. Mieli-Vergani, S. Robson, 2016 .

Dysfunctional CD39POS regulatory T cells and aberrant control of T‐helper type 17 cells in autoimmune hepatitis

D. Vergani, G. Mieli-Vergani, C. Grant, 2014, Hepatology.

DYSFUNCTIONAL CD39 REGULATORY T CELLS AND ABERRANT CONTROL OF T HELPER TYPE 17 CELLS IN AUTOIMMUNE HEPATITIS Short title: CD39 REGULATORY T CELLS IN AUTOIMMUNE HEPATITIS

D. Vergani, G. Mieli-Vergani, S. Robson, 2016 .

Autoimmune hepatitis after liver transplantation.

D. Vergani, G. Mieli-Vergani, C. Grant, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reconstitution of nude mouse T cell function in vivo: IL 2-independent effect of human T cells.

H. Dosch, C. Grant, D. White, 1985, Journal of immunology.